Twin Tree Management
SYRS

Twin Tree Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Twin Tree Management’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-62
Closed -$3K – 1658
2018
Q4 		$3K Buy
+62
New +$4.71K ﹤0.01% 1282

Other funds holding SYRS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Twin Tree Management's SYRS Position: Q1 2019 in Review

Twin Tree Management sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q1 2019, closing a stake of 62 shares — an estimated $3K sold.

Twin Tree Management first reported a position in SYRS in Q4 2018 and held it in 1 quarter. The position peaked at $3K in Q4 2018. 65 funds tracked by Wall St. Rank hold SYRS as of Q1 2019.

  • Twin Tree Management reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Twin Tree Management sold 62 Syros Pharmaceuticals, Inc. Common Stock shares in Q1 2019, an estimated $3K.
  • Twin Tree Management first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q4 2018 and held it in 1 quarter.
  • Twin Tree Management's Syros Pharmaceuticals, Inc. Common Stock position peaked at $3K in Q4 2018.
  • 65 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q1 2019.

Based on Twin Tree Management's 13F filing for Q1 2019, filed 10 May 2019.